The de Haas-van Alphen effect across the metamagnetic transition in Sr3_3Ru2_2O7_7

We report a study of the de Haas-van Alphen (dHvA) effect on the itinerant metamagnet Sr$_3$Ru$_2$O$_7$. Extremely high sample purity allows the observation of dHvA oscillations both above and below the metamagnetic transition field of 7.9 T. The quasiparticle masses are fairly large away from the transition, and are enhanced by up to an extra factor of three as the transition is approached, but the Fermi surface topography change is quite small. The results are qualitatively consistent with a field-induced Stoner transition in which the mass enhancement is the result of critical fluctuations.Comment: 4 pages, 3 figure

First Observation of Quantum Oscillations in the Ferromagnetic Superconductor UCoGe

We succeeded in growing high quality single crystals of the ferromagnetic superconductor UCoGe and measured the magnetoresistance at fields up to 34T. The Shubnikov-de Haas signal was observed for the first time in a U-111 system (UTGe, UTSi, T: transition metal). A small pocket Fermi surface (F~1kT) with large cyclotron effective mass 25m0 was detected at high fields above 22T, implying that UCoGe is a low carrier system accompanyed with heavy quasi-particles. The observed frequency decreases with increasing fields, indicating that the volume of detected Fermi surface changes nonlinearly with field. The cyclotron mass also decreases, which is consistent with the decrease of the A coefficient of resistivity.Comment: 5 pages, 5 figures, accepted for publication in J. Phys. Soc. Jp

High-field magnetization of the 3d heavy-fermion system LiV2_2O4−d_{4-d} (d = 0, 0.08)

Metamagnetic behavior has been observed in LiV2O4 powder sample around 38 T at 4.2 K. On the other hand, magnetization for oxygen deficient LiV2O3.92 shows no indication of metamagnetism up to 40 T, and shows substantially reduced magnetic moment compared to that of LiV2O4. These results suggest that ferromagnetic interaction is strongly enhanced by magnetic fields in LiV2O4, whereas antiferromagnetic interaction is dominant in LiV2O3.92.Comment: 9 pages, 3 figures, to be published in J. Phys.: Condens. Matte

Global update on the susceptibility of humam influenza viruses to neuraminidase inhibitors 2012-2013

Emergence of influenza viruses with reduced susceptibility to neuraminidase inhibitors (NAIs) is sporadic, often follows exposure to NAIs, but occasionally occurs in the absence of NAI pressure. The emergence and global spread in 2007/2008 of A(H1N1) influenza viruses showing clinical resistance to oseltamivir due to neuraminidase (NA) H275Y substitution, in the absence of drug pressure, warrants continued vigilance and monitoring for similar viruses. Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza (WHO CCs) tested 11,387 viruses collected by WHO-recognized National Influenza Centres (NIC) between May 2012 and May 2013 to determine 50% inhibitory concentration (IC50) data for oseltamivir, zanamivir, peramivir and laninamivir. The data were evaluated using normalized IC50 fold-changes rather than raw IC50 data. Nearly 90% of the 11,387 viruses were from three WHO regions: Western Pacific, the Americas and Europe. Only 0.2% (n=27) showed highly reduced inhibition (HRI) against at least one of the four NAIs, usually oseltamivir, while 0.3% (n=39) showed reduced inhibition (RI). NA sequence data, available from the WHO CCs and from sequence databases (n=3661), were screened for amino acid substitutions associated with reduced NAI susceptibility. Those showing HRI were A(H1N1)pdm09 with NA H275Y (n=18), A(H3N2) with NA E119V (n=3) or NA R292K (n=1) and B/Victoria-lineage with NA H273Y (n=2); amino acid position numbering is A subtype and B type specific. Overall, approximately 99% of circulating viruses tested during the 2012-2013 period were sensitive to all four NAIs. Consequently, these drugs remain an appropriate choice for the treatment and prophylaxis of influenza virus infections

High-Field Fermi Surface Properties in the Low Carrier Heavy Fermion Compound URu2Si2

We performed the Shubnikov-de Haas (SdH) experiments of the low carrier heavy fermion compound URu2Si2 at high fields up to 34T and at low temperatures down to 30mK. All main SdH branches named alpha, beta and gamma were observed for all the measured field-directions (H // [001] -> [100], [100] -> [110] and [001] -> [110]), indicating that these are attributed to the closed Fermi surfaces with nearly spherical shapes. Anomalous split of branch alpha was detected for the field along the basal plane, and the split immediately disappears by tilting the field to [001] direction, implying a fingerprint of the hidden order state. High field experiments reveal the complicated field-dependence of the SdH frequencies and the cyclotron masses due to the Zeeman spin-splitting associated with the Fermi surface reconstruction in the hidden order state with small carrier numbers. A new SdH branch named omega with large cyclotron mass of 25m0 was detected at high fields above 23T close to the hidden order instabilities.Comment: 6 pages, 7 figures, accepted for publication in J. Phys. Soc. Jp

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016.

Four World Health Organization (WHO) Collaborating Centres for Reference and Research on Influenza and one WHO Collaborating Centre for the Surveillance, Epidemiology and Control of Influenza (WHO CCs) assessed antiviral susceptibility of 14,330 influenza A and B viruses collected by WHO-recognized National Influenza Centres (NICs) between May 2015 and May 2016. Neuraminidase (NA) inhibition assay was used to determine 50% inhibitory concentration (IC50) data for NA inhibitors (NAIs) oseltamivir, zanamivir, peramivir and laninamivir. Furthermore, NA sequences from 13,484 influenza viruses were retrieved from public sequence databases and screened for amino acid substitutions (AAS) associated with reduced inhibition (RI) or highly reduced inhibition (HRI) by NAIs. Of the viruses tested by WHO CCs 93% were from three WHO regions: Western Pacific, the Americas and Europe. Approximately 0.8% (n = 113) exhibited either RI or HRI by at least one of four NAIs. As in previous seasons, the most common NA AAS was H275Y in A(H1N1)pdm09 viruses, which confers HRI by oseltamivir and peramivir. Two A(H1N1)pdm09 viruses carried a rare NA AAS, S247R, shown in this study to confer RI/HRI by the four NAIs. The overall frequency of A(H1N1)pdm09 viruses containing NA AAS associated with RI/HRI was approximately 1.8% (125/6915), which is slightly higher than in the previous 2014-15 season (0.5%). Three B/Victoria-lineage viruses contained a new AAS, NA H134N, which conferred HRI by zanamivir and laninamivir, and borderline HRI by peramivir. A single B/Victoria-lineage virus harboured NA G104E, which was associated with HRI by all four NAIs. The overall frequency of RI/HRI phenotype among type B viruses was approximately 0.6% (43/7677), which is lower than that in the previous season. Overall, the vast majority (>99%) of the viruses tested by WHO CCs were susceptible to all four NAIs, showing normal inhibition (NI). Hence, NAIs remain the recommended antivirals for treatment of influenza virus infections. Nevertheless, our data indicate that it is prudent to continue drug susceptibility monitoring using both NAI assay and sequence analysis